Medicare Benefits Schedule - Item 73430

Fluorescence in-situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic solid tumour, if:

(a)     the tumour is at risk of being caused by a neurotrophic receptor tyrosine kinase (NTRK) gene fusion as determined by either:

                   (i)        occurring in a child less than 18 years of age; or

                   (ii)        being mammary analogue secretory carcinoma of the salivary gland; or

                   (iii)        being secretory breast carcinoma; and

(b)    the test is requested by a specialist or consultant physician to determine if requirements relating to NTRK gene fusion status for access to a tropomyosin receptor kinase (Trk) inhibitor under the Pharmaceutical Benefits Scheme are fulfilled

This item cannot be claimed if item 73433 has been claimed for the same patient during the same cancer diagnosis

Applicable only once per cancer diagnosis

Fee: $400.00 Benefit: 75% = $300.00 85% = $340.00

• Previous - Item 73429
• Next - Item 73431